Central nervous system infectious and metabolic abnormalities are common in HIV-positive patients. Drug therapy, opportunistic infections, the clinical course of HIV disease itself, and very rarely iodinated radiographic contrast agents can all be linked to these abnormalities. The following case describes an HIV-seropositive patient who developed encephalopathy after undergoing a cervical myelogram that utilized iopamidol dye (Isovue-M 300 mg/mL).
Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient. Publishing Authors By Initials
Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Proceedings (Baylor University. Medical Center)
VOLUME: 20
Page Numbers: 39-40
Journal Abbreviation:
ISSN: 0899-8280
DAY: 26
MONTH: Jan
YEAR: 2007
Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9302033
Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient.
AFFILIATION: University of Oklahoma College of Pharmacy, Tulsa, Oklahoma (Stroup); and Department of Internal Medicine, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma (Stephens, Baker).
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Proc (Bayl Univ Med Cent)
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Iopamidol-induced meningoencephalopathy in an HIV-seropositive patient Related Publications